Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-02-02 @ 1:56 AM
Study NCT ID:
NCT00119392
Status:
COMPLETED
Last Update Posted:
2018-06-29
First Post:
2005-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-cell Chronic Lymphocytic Leukemia | View |
| None | Nodal Marginal Zone B-cell Lymphoma | View |
| None | Recurrent Adult Burkitt Lymphoma | View |
| None | Recurrent Adult Diffuse Large Cell Lymphoma | View |
| None | Recurrent Adult Diffuse Mixed Cell Lymphoma | View |
| None | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | View |
| None | Recurrent Adult Grade III Lymphomatoid Granulomatosis | View |
| None | Recurrent Adult Immunoblastic Large Cell Lymphoma | View |
| None | Recurrent Adult Lymphoblastic Lymphoma | View |
| None | Recurrent Grade 1 Follicular Lymphoma | View |
| None | Recurrent Grade 2 Follicular Lymphoma | View |
| None | Recurrent Grade 3 Follicular Lymphoma | View |
| None | Recurrent Mantle Cell Lymphoma | View |
| None | Recurrent Marginal Zone Lymphoma | View |
| None | Recurrent Small Lymphocytic Lymphoma | View |
| None | Splenic Marginal Zone Lymphoma | View |
| None | Waldenström Macroglobulinemia | View |
Keywords: